entertainment -WSS

entertainment

author：comprehensive 2025-08-04 12:32:06 - browse：633

The bacterium A. baylyi was engineered to detect a common cancer mutation. Courtesy of Josephine Wright

Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands of colonoscopies a year, seeking and destroying precancerous polyps. It’s a practically surefire way to prevent colorectal cancer, but an unpleasant experience for patients. The future, Worthley hopes, will be much less onerous — and he’s developing a technology that, if it works one day, might make the experience more of a piece of cake.

Or, rather, a cup of yogurt — containing engineered bacteria that can detect and deliver a treatment for colorectal polyps or cancer. Worthley and colleagues at the University of California, San Diego, and the University of Adelaide published results in Science on Thursday that show they are one step closer to that far-off dream. In their paper, the researchers show a proof-of-concept engineered bacterium that can detect cancer DNA in the guts of mice and react to it by turning on certain cellular circuitry.

“I think it’s really cool. It introduces a new concept for how you can use cells as a sensor for something happening inside other cells,” said Mikhail Shapiro, a chemical and medical engineer at the California Institute of Technology who did not work on the study. “That can flip a switch inside those cells. In this case, it’s used for diagnostic output, but in principle it could be used for other things.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

WSS

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Artificial intelligence use in health care faces greater scrutiny in 2024

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Congress must protect the remaining independent doctors

Biden jokes that Republicans may impeach him because inflation is starting to cool down

knowledge

entertainment

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Abbott's new heart device gets FDA advisory panel nod

As demand for Covid shots wanes, Moderna seeks its next success

CDC: Cases of alpha

In Memoriam: Notable people who died in 2023

Why don't Americans have at

State Dept. review finds Biden bears some blame for Afghanistan failures

Here’s what’s in the FDA plan to include pregnant women in clinical trials

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Latigo launches with $135 million for Vertex

explore

STAT Boddities: What happens to the brain when we get scared?

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

The mammogram wars are not over

Report cites 'urgent' need to recruit more diverse clinical trial participants

Having children helps parents live longer, especially after age 80

Bernie Sanders gets little from pharma CEOs on drug prices

hotspot

hotspot

knowledge

knowledge